Vivalyx

We are excited to share that our organ vitality technology has garnered the attention of industry leaders. During our exclusive meeting, Bill Anderson, CEO of Bayer, expressed his enthusiasm for our product, recognizing its potential to make a significant difference in healthcare. This endorsement from such a respected figure in the life sciences industry reaffirms our commitment to revolutionizing organ preservation. A heartfelt thank you to Bill Anderson's team for organizing the meeting. We look forward to staying in touch. #Vivalyx #OrganVitalityTech #TechnologySavesTheWorld #MedTech #OrganTransplantation René H. Tolba Malte Brettel Benedict Doorschodt Andreas Schumacher

🔬 Thrilling News! We are excited to share that our CTO, Benedict Doorschodt, presented groundbreaking data at the American Transplant Congress (ATC) in Philadelphia. The findings highlighted: During 24h HOPE of kidney grafts, Omnisol showed better results with regards to renal function and damage than the current golden standard UW-MPS, as well as demonstrating better histological assessment parameters. This advancement underscores our commitment to innovation and improving outcomes in organ transplantation. Kudos to Lisa Ernst, Christian Bleilevens, René H. Tolba, Benedict Doorschodt and the entire team for their dedication! #Vivalyx #TechnologySavesTheWorld #MedTech #OrganTransplantation #OrganDonation #Innovation #LifeScience

🚀 Exciting News from Vivalyx! 🚀 We are thrilled to announce the successful closure of our oversubscribed Seed funding round, raising over €5 million! This marks a pivotal moment for us as we finance the clinical studies for our groundbreaking organ preservation technology. A heartfelt thank you to our new and existing investors, including Brightlands Venture Partners, TVF | TechVision Fonds, GOOSE Capital, Andrej Henkler, Angel Invest, Arve Capital and Springboard Health Angels. Your faith in our vision energizes our mission to revolutionize organ transplantation. Read more about how we're planning to extend vitality of donor organs for a significant impact on healthcare systems worldwide. https://lnkd.in/ecXWM63P Have you considered organ donation for yourself? Join the discussion and share your thoughts! 💙 Our supporters: Alexander Luik, Priv.-Doz. Dr. med. Alexander Younsi, FEBNS, Andreas Schmidt (PhD.), Andrej Henkler, Angel Invest (Jens Lapinski, John von Berenberg-Consbruch), Ariel Dora Stern, Arve Capital (Christian Schierholz, Philipp Harnischfeger), Ashok Rao, Audrey Tsang, Bernd Heinrichs, Brightlands Venture Partners (Luc Starmans), Dr. Carina Ruwolt, Christian Stiebner, Christopher Oezbek, Dr. Daniel Schellong, David Greenberg, GOOSE Capital (Andrew Nicholson), Ingo Hillen, Jan Adams, Katharina Klohe, Klaus-Dieter Langner, Lisa Ernst, Nicolas Weber, Dr. Ole Dammann, Sebastian Johnston, Till Erdmann, Troy Dale, TVF | TechVision Fonds (Bernhard Kugel, Dr. Lars Gussen), Dr. Valentin Schmitt, Dr. Yoni Goldwasser #Vivalyx #TechnologySavesTheWorld #MedTech #OrganTransplantation #OrganDonation #Innovation #LifeScience